Personal information

United States

Activities

Employment (2)

University of Tennessee Health Science Center: Memphis, TN, US

2017-09-01 to present | Assistant Professor (Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Jiawang Liu

Xavier University of Louisiana: New Orleans, LA, US

2015-05-05 to 2017-07-31 | Research Scientist (Chemistry)
Employment
Source: Self-asserted source
Jiawang Liu

Education and qualifications (1)

Peking University: Beijing, Beijing, CN

2002-09-01 to 2007-07-04 | Ph.D. (Medicinal Chemistry)
Education
Source: Self-asserted source
Jiawang Liu

Works (50 of 60)

Items per page:
Page 1 of 2

RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety.

International journal of nanomedicine
2021-08-16 | Journal article
Source: Self-asserted source
Jiawang Liu

EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

Journal of medicinal chemistry
2021-08-05 | Journal article
Source: Self-asserted source
Jiawang Liu

Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies.

Pharmaceuticals (Basel, Switzerland)
2021-07-26 | Journal article
Source: Self-asserted source
Jiawang Liu

A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway.

Journal of nanobiotechnology
2021-04-23 | Journal article
Source: Self-asserted source
Jiawang Liu

Associations of prenatal metabolomics profiles with early childhood growth trajectories and obesity risk in African Americans: the CANDLE study.

International journal of obesity (2005)
2021-04-06 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.

Blood
2020-11-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Identification of Anti-tuberculosis Compounds From Aurone Analogs.

Frontiers in microbiology
2020-05-20 | Journal article
Source: Self-asserted source
Jiawang Liu

GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models.

Breast cancer research and treatment
2020-02-06 | Journal article
Source: Self-asserted source
Jiawang Liu

Rv1075c of Mycobacterium tuberculosis is a GDSL-Like Esterase and Is Important for Intracellular Survival.

The Journal of infectious diseases
2019-07-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Coumarins and P450s, Studies Reported to-Date

Molecules
2019-04 | Journal article | Author
Contributors: Maryam Foroozesh; Jayalakshmi Sridhar; Navneet Goyal; Jiawang Liu
Source: check_circle
Multidisciplinary Digital Publishing Institute

A joint analysis of metabolomic profiles associated with muscle mass and strength in Caucasian women.

Aging
2018-10-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Inhibition of breast tumor growth in mice after treatment with ceramide analog 315.

Anti-cancer drugs
2018-10-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Metabolomic profiles associated with bone mineral density in US Caucasian women.

Nutrition & metabolism
2018-08-10 | Journal article
Source: Self-asserted source
Jiawang Liu

Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors.

ACS medicinal chemistry letters
2018-01-08 | Journal article
Source: Self-asserted source
Jiawang Liu

Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD).

Oncotarget
2017-10-10 | Journal article
Source: Self-asserted source
Jiawang Liu

Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.

Molecules (Basel, Switzerland)
2017-07-08 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

OPTIMIZATION OF SCALE-UP SYNTHESIS OF ANTI-CANCER CERAMIDE ANALOG 315.

Journal of undergraduate chemistry research
2017-01-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme.

Drug metabolism letters
2017-01-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.

ACS medicinal chemistry letters
2016-11-29 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).

Journal of medicinal chemistry
2016-08-29 | Journal article
Source: Self-asserted source
Jiawang Liu

Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.

Future medicinal chemistry
2015-12-16 | Journal article
Source: Self-asserted source
Jiawang Liu

Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis.

International journal of nanomedicine
2015-11-04 | Journal article
Source: Self-asserted source
Jiawang Liu

Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome P450 inhibition: a patent evaluation WO2015048311 (A1).

Expert opinion on therapeutic patents
2015-10-29 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.

Journal of medicinal chemistry
2015-08-10 | Journal article
Source: Self-asserted source
Jiawang Liu

Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13.

Xenobiotica; the fate of foreign compounds in biological systems
2015-08-06 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

Ethynylflavones, highly potent, and selective inhibitors of cytochrome P450 1A1.

Chemical research in toxicology
2014-07-29 | Journal article
Source: Self-asserted source
Jiawang Liu

3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells.

Bioorganic & medicinal chemistry
2014-01-08 | Journal article
Source: Self-asserted source
Jiawang Liu

Cytochrome P450 family 1 inhibitors and structure-activity relationships.

Molecules (Basel, Switzerland)
2013-11-25 | Journal article
Source: Self-asserted source
Jiawang Liu

DESIGN, SYNTHESIS, AND EVALUATION OF CARBAZOLE ANALOGS AS POTENTIAL CYTOCHROME P450 INHIBITORS.

Journal of undergraduate chemistry research
2013-09-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.

ACS nano
2013-08-29 | Journal article
Source: Self-asserted source
Jiawang Liu

A review of ceramide analogs as potential anticancer agents.

Future medicinal chemistry
2013-08-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.

Journal of medicinal chemistry
2013-05-02 | Journal article
Source: Self-asserted source
Jiawang Liu

Potent mechanism-based inactivation of cytochrome P450 2B4 by 9-ethynylphenanthrene: implications for allosteric modulation of cytochrome P450 catalysis.

Biochemistry
2013-01-04 | Journal article
Source: Self-asserted source
Jiawang Liu

DESIGN, SYNTHESIS, AND EVALUATION OF A FAMILY OF PROPARGYL PYRIDINYL ETHERS AS POTENTIAL CYTOCHROME P450 INHIBITORS.

Journal of undergraduate chemistry research
2013-01-01 | Journal article
Source: Self-asserted source
Jiawang Liu

The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.

Molecular bioSystems
2012-10-01 | Journal article
Source: Self-asserted source
Jiawang Liu

Poly-α,β-DL-aspartyl-L-cysteine: a novel nanomaterial having a porous structure, special complexation capability for Pb(II), and selectivity of removing Pb(II).

Chemical research in toxicology
2012-09-04 | Journal article
Source: Self-asserted source
Jiawang Liu

Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.

Molecules (Basel, Switzerland)
2012-08-03 | Journal article
Source: Self-asserted source
Jiawang Liu

7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.

Chemical research in toxicology
2012-04-10 | Journal article
Source: Self-asserted source
Jiawang Liu

Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction.

Metallomics : integrated biometal science
2012-04-10 | Journal article
Source: Self-asserted source
Jiawang Liu

Synthesis and in vivo lead detoxification evaluation of Poly-α,β-dl-aspartyl-l-methionine.

Chemical research in toxicology
2012-02-07 | Journal article
Source: Self-asserted source
Jiawang Liu

Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.

Chemical research in toxicology
2012-01-10 | Journal article
Source: Self-asserted source
Jiawang Liu

Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.

Drug metabolism letters
2012-01-01 | Journal article
Source: Self-asserted source
Jiawang Liu

A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin.

Molecular bioSystems
2011-10-18 | Journal article
Source: Self-asserted source
Jiawang Liu

A class of novel N-(1-methyl-β-carboline-3-carbonyl)-N'-(aminoacid-acyl)-hydrazines: aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis.

European journal of medicinal chemistry
2011-09-24 | Journal article
Source: Self-asserted source
Jiawang Liu

Pyrolo[1,2:4,5]-1,4-dioxopyrazino[1,2:1,6]pyrido[3,4-b]indoles: a group of urokinase inhibitors, their synthesis, and stereochemistry-dependent activity.

ChemMedChem
2011-09-23 | Journal article
Source: Self-asserted source
Jiawang Liu

From Cerius² based stereoview to mouse and enzyme: the model systems for discovery of novel urokinase inhibitors.

Molecular bioSystems
2011-07-06 | Journal article
Source: Self-asserted source
Jiawang Liu

HPLC-MS aided PC12 cell systems: to quantitatively monitor the conversion of nitronyl nitroxide in biological systems with and without NO.

Molecular bioSystems
2011-03-14 | Journal article
Source: Self-asserted source
Jiawang Liu

2-Substituted (S)-2-(3,3-dimethyl-1-oxo-10,10a-dihydroimidazo[1,5-b]isoquinolin-2(1H,3H,5H)-yl)acetic acids: Conformational prediction, synthesis, anti-thrombotic and vasodilative evaluation.

Bioorganic & medicinal chemistry
2010-12-05 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM): its anti-cancer efficacy and intercalation mechanism identified via multi-model systems.

Molecular bioSystems
2010-11-30 | Journal article
Source: Self-asserted source
Jiawang Liu
grade
Preferred source (of 2)‎

Lead detoxification activity and ADMET hepatotoxicity of N-(alpha-L-arabino-furanos-1-yl)-L-cysteine.

Chemical research in toxicology
2010-07-01 | Journal article
Source: Self-asserted source
Jiawang Liu
Items per page:
Page 1 of 2

Peer review (2 reviews for 2 publications/grants)

Review activity for Heliyon. (1)
Review activity for Journal of medicinal chemistry. (1)